Product Name

  • Name

    Erdosteine

  • EINECS 642-172-5
  • CAS No. 84611-23-4
  • Article Data3
  • CAS DataBase
  • Density 1.48 g/cm3
  • Solubility
  • Melting Point 156-160 °C
  • Formula C8H11NO4S2
  • Boiling Point 590.4 °C at 760 mmHg
  • Molecular Weight 249.312
  • Flash Point 310.8 °C
  • Transport Information
  • Appearance white or almost white crystalline powder
  • Safety
  • Risk Codes R36/37/38
  • Molecular Structure Molecular Structure of 84611-23-4 (Erdosteine)
  • Hazard Symbols
  • Synonyms Aceticacid, [[2-oxo-2-[(tetrahydro-2-oxo-3-thienyl)amino]ethyl]thio]- (9CI);Dithiosteine;RV 144;Secresolv;
  • PSA 134.07000
  • LogP 0.34340

Erdosteine Chemical Properties

Molecule structure of Erdosteine (CAS NO.84611-23-4):

IUPAC Name: 2-[2-Oxo-2-[(2-oxothiolan-3-yl)amino]ethyl]sulfanylacetic acid 
Molecular Weight: 249.30724 g/mol
Molecular Formula: C8H11NO4S2 
Density: 1.48 g/cm3 
Melting Point: 156-160°C
Boiling Point: 590.4 °C at 760 mmHg 
Flash Point: 310.8 °C
Index of Refraction: 1.615
Molar Refractivity: 58.58 cm3
Molar Volume: 167.7 cm3
Surface Tension: 69.5 dyne/cm
Enthalpy of Vaporization: 96.22 kJ/mol
Vapour Pressure: 1.82E-15 mmHg at 25 °C
XLogP3: -0.1
H-Bond Donor: 2
H-Bond Acceptor: 4
Rotatable Bond Count: 5
Tautomer Count: 4
Exact Mass: 249.012949
MonoIsotopic Mass: 249.012949
Topological Polar Surface Area: 83.5
Heavy Atom Count: 15
Canonical SMILES: C1CSC(=O)C1NC(=O)CSCC(=O)O
InChI: InChI=1S/C8H11NO4S2/c10-6(3-14-4-7(11)12)9-5-1-2-15-8(5)13/h5H,1-4H2,(H,9,10)(H,11,12)
InChIKey: QGFORSXNKQLDNO-UHFFFAOYSA-N
Classification Code: Drug / Therapeutic Agent; Expectorants; Respiratory System Agents

Erdosteine Uses

Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine.
 Erdosteine (CAS NO.84611-23-4) is used as expectorant cough medicine for acute and chronic bronchitis, emphysema and other obstructive diseases.

Erdosteine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous > 3500mg/kg (3500mg/kg)   Drugs under Experimental and Clinical Research. Vol. 14, Pg. 693, 1988.
 
mouse LD50 oral > 10gm/kg (10000mg/kg)   European Patent Application. Vol. #0061386,
rat LD50 intravenous > 3500mg/kg (3500mg/kg)   European Patent Application. Vol. #0061386,
rat LD50 oral > 10gm/kg (10000mg/kg)   European Patent Application. Vol. #0061386,

 

Erdosteine Specification

 Erdosteine (CAS NO.84611-23-4) is also named as ((2-Oxo-2-((tetrahydro-2-oxo-3-thienyl)amino)ethyl)thio)acetic acid
(+-)-((((Tetrahydro-2-oxo-3-thienyl)carbamoyl)methyl)thio)acetic acid ; Acide ((2-oxo-3-tetrahydrothienylcarbamoyl)-methylthio)acetique ; Acide ((2-oxo-3-tetrahydrothienylcarbamoyl)-methylthio)acetique [French] ; DL-S-(2-(N-3-(2-
Oxotetrahydrotheinyl)acetamido))thioglycolic acid ; Erdosteinum ; Erdosteinum [Latin] ; PV 144 ; RV 144 ; UNII-76J0853EKA . Erdosteine (CAS NO.84611-23-4) is white or almost white crystalline powder.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View